26-Year-Old Woman with Rare and Life-Threating Pregnancy Tumour successfully treated at Fortis Hospital Nagarbhavi

▴ Fortis Hospital Nagarbhavi
Rare Pregnancy Tumors are reported in 2 out of every 1000 Pregnancies.

Bengaluru, 15 January 2026: Doctors at Fortis Hospital, Nagarbhavi successfully treated a Life-threatening pregnancy-related tumour in a 26-year-old woman, while preserving her uterus and fertility. The patient was diagnosed with Gestational Trophoblastic Neoplasia - a rare pregnancy-related tumour characterized by abnormal tissue growth inside the uterus. The tumor posed a high risk of sudden, severe internal bleeding if not handled with extreme caution. The rare case was managed through a multi-disciplinary approach led by Dr. Nirmala Chandrashekar, Consultant – Obstetrics & Gynaecology, Fortis Hospital, Nagarbhavi.

When admitted at Fortis Nagarbhavi, the patient was presented with complaints of missed abortion (a type of miscarriage where the pregnancy has stopped developing) and continuous vaginal spotting. Her ultrasound scans showed abnormal intrauterine mass with significantly increased blood flow. In such cases, emergency removal of the uterus becomes necessary to save the patient’s life. Given the gravity of the situation, the patient’s family initially requested hysterectomy. However, after thorough evaluation, the Fortis Nagarbhavi medical team opted for a carefully planned, step-by-step conservative approach aimed at preserving the patient’s fertility.

The team of doctors, first performed a procedure to temporarily block blood supply to the uterus, significantly reducing the risk of massive bleeding. This was followed by a meticulously monitored removal of the abnormal tissue under ultrasound guidance. The patient responded well to the treatment, experienced no major complications, and recovered smoothly. Subsequent tests confirmed a partial molar pregnancy, a rare but treatable condition. After treatment, the patient’s pregnancy hormone levels returned to normal, confirming complete recovery without the need for uterus removal.

Giving details of the case, Dr Nirmala ChandrashekarConsultant – Obstetrics & Gynaecology, Fortis Hospital, Nagarbhavi said, “This was an extremely challenging case due to the high risk of sudden and severe bleeding. Our foremost priority was to save the patient’s life while making every possible effort to preserve her uterus. By carefully reducing uterine blood flow first and then removing the abnormal tissue under ultrasound guidance, we were able to achieve a safe and fertility-preserving outcome.”

Expressing her gratitude, the patient said, “I feared the worst, but I never imagined it could be so serious. The doctors at Fortis Nagarbhavi explained everything patiently and treated me with great care. I am deeply grateful that my life was saved and that my ability to have children in the future has been conserved.”

Mr Ratheef Naik, Facility Director, Fortis Hospital, Nagarbhavi, added, “Gestational trophoblastic tumours demand early diagnosis and coordinated multidisciplinary expertise. At Fortis Nagarbhavi, we are equipped to deliver advanced, conservative and fertility-preserving care when patients seek timely treatment. This successful intervention once again reinforces our position as a leading tertiary care centre for managing high-risk and complex obstetric conditions, combining clinical excellence with compassionate, patient-centric care.”

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Clinical Interventions in Chronic Hepatitis B and C: Antiviral Efficacy, Liver Fibrosis Scoring, and Monitoring August 11, 2026
Common Health Mistakes Indians Should Avoid: A Practical Guide to Everyday WellnessAugust 11, 2026
How to Build a Healthy Lifestyle After 40: A Practical Guide for Indian AdultsAugust 11, 2026
Milk Microbiome Could Hold New Clues to Lifelong Health, Experts SayAugust 10, 2026
Globally Renowned Dermatologist and Sesderma Founder Professor Dr. Gabriel Serrano to Visit India to Showcase Cutting-Edge Derma-Tech for Indian Skincare at Scientific Symposiums Hosted by Iberia PharmaceuticalsAugust 10, 2026
Sharda Hospital Celebrates World Breastfeeding Week with a Week-Long Awareness ProgrammeAugust 10, 2026
Swinburne University of Technology Opens Applications for Master of Engineering ScienceAugust 10, 2026
GLP-1 Receptor Agonists: A New Era in Weight Loss TreatmentAugust 10, 2026
Immunotherapy vs. Chemotherapy: Understanding the Mechanisms of Precision OncologyAugust 10, 2026
Mitigating Tech-Induced Ailments: Managing Screen Time, Sedentary Lifestyles, and Dry Eye SyndromeAugust 10, 2026
The Blueprint of Validation: Navigating Medical AI’s "Reckoning Year"August 10, 2026
The Future of Smart Hospitals: Redefining Healthcare Delivery in India August 10, 2026
Healthcare Data Security in India: Risks, Threats, and Best Practices for a Digital-First Health EcosystemAugust 10, 2026
The Science of Resilience: Psychological Strategies for Modern StressAugust 08, 2026
The Science of Fasting: 2026 Research on Autophagy and LongevityAugust 08, 2026
Early Markers of Insulin Resistance: Moving Beyond Fasting Blood SugarAugust 08, 2026
Healthcare Management Challenges in India: What Hospital Leaders Must Address NowAugust 08, 2026
Importance of Patient Safety: Why Every Hospital in India Must Prioritize ItAugust 08, 2026
Decoding Fatty Liver Disease: Symptoms, Reversibility, and the MASLD/NAFLD SpectrumAugust 07, 2026
Heart-Healthy Dietary Patterns: Translating Clinical Nutrition Guidelines into Daily MealsAugust 07, 2026